| 23251 | 23251 | The Effect of Acupuncture Protocol Involving in Weizhong (BL4) and Huantiao (GB30) Points in Treating Ankylosing Spondylitis | Enrolling by invitation | No Results Available | Ankylosing Spondylitis | Other: Weizhong and Huantiao|Other: A-shi point | https://ClinicalTrials.gov/show/NCT02260310 |
| 23252 | 23252 | A Study of Wrist Actigraphy in Overweight and Obese Adults With Sleep Disorders | Completed | No Results Available | Sleep Disorders | Device: Wrist Actigraphy(motion sensors)with light sensors-Jawbone Up 2 | https://ClinicalTrials.gov/show/NCT02260297 |
| 23253 | 23253 | The Effect of Acupotome in Treating Ankylosing Spondylitis | Enrolling by invitation | No Results Available | Ankylosing Spondylitis | Other: Acupotome(needle knife)|Other: Control | https://ClinicalTrials.gov/show/NCT02260284 |
| 23254 | 23254 | Florida Neonatal Neurologic Network | Enrolling by invitation | No Results Available | Hypoxic-Ischemic Encephalopathy | Other: Database Entry/Biospecimen Collection | https://ClinicalTrials.gov/show/NCT02260271 |
| 23255 | 23255 | Neuromuscular Blockade for Post-Cardiac Arrest Care | Recruiting | No Results Available | Cardiac Arrest | Drug: Rocuronium|Drug: Normal Saline | https://ClinicalTrials.gov/show/NCT02260258 |
| 23256 | 23256 | Stepping Up for Safety: Improving Teamwork at the Planned Parenthood Affiliates Through the TeamSTEPPS Model | Enrolling by invitation | No Results Available | Improving Team Work at the Planned Parenthood Affiliates | Behavioral: Team training using the TeamSTEPPS model | https://ClinicalTrials.gov/show/NCT02260245 |
| 23257 | 23257 | Worksite Exercise Intervention Effects on Cardiovascular Disease Risk Factors and Physical Activity Levels Among Healthy Employees | Completed | No Results Available | Exercise Therapy | Other: exercise training | https://ClinicalTrials.gov/show/NCT02260232 |
| 23258 | 23258 | Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma | Active, not recruiting | No Results Available | Neovascular Glaucoma | Procedure: Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2 | https://ClinicalTrials.gov/show/NCT02260219 |
| 23259 | 23259 | Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion | Recruiting | No Results Available | Pericardial Effusion | Drug: Colchicine | https://ClinicalTrials.gov/show/NCT02260206 |
| 23260 | 23260 | 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Subjects With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis | Active, not recruiting | No Results Available | Anemia|End Stage Renal Disease | Drug: AKB-6548|Drug: AKB-6548|Drug: AKB-6548 | https://ClinicalTrials.gov/show/NCT02260193 |
| 23261 | 23261 | Study of A-101 for the Treatment of Seborrheic Keratosis | Completed | No Results Available | Seborrheic Keratosis | Drug: A-101 | https://ClinicalTrials.gov/show/NCT02260180 |
| 23262 | 23262 | Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol | Recruiting | No Results Available | Alzheimer's Disease|Dementia | Other: A mix of natural treatments and medications | https://ClinicalTrials.gov/show/NCT02260167 |
| 23263 | 23263 | Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointestinal Spasm | Recruiting | No Results Available | Post-cholecystectomy Gastrointestinal Spasms | Drug: Mebeverine | https://ClinicalTrials.gov/show/NCT02260154 |
| 23264 | 23264 | Treating Alzheimer's and Dementia With D-ribose | Recruiting | No Results Available | Alzheimers|Dementia | Dietary Supplement: d-ribose | https://ClinicalTrials.gov/show/NCT02260141 |
| 23265 | 23265 | Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery | Not yet recruiting | No Results Available | Cancer Esophagus|Pancreatic Cancer | Other: Chewing gum | https://ClinicalTrials.gov/show/NCT02260128 |
| 23266 | 23266 | A Randomized Multi-centre Study to Assess the Safety and Manageability of a Laparoscopic Adhesion Barrier in Women Undergoing Gynecologic Laparoscopic Surgery Followed by Second Look Laparoscopy | Active, not recruiting | No Results Available | Tissue Adhesions | Device: LABSâ„¢|Procedure: Surgical Control | https://ClinicalTrials.gov/show/NCT02260115 |
| 23267 | 23267 | Temocillin Pharmacokinetics in Paediatrics | Not yet recruiting | No Results Available | Infection|Liver Dysfunction|Urinary Tract Infection | Drug: Temocillin | https://ClinicalTrials.gov/show/NCT02260102 |
| 23268 | 23268 | Telmisartan in Mild to Moderate Hypertensive Patients | Completed | No Results Available | Hypertension | Drug: Low dose of telmisartan|Drug: High dose of telmisartan|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02260089 |
| 23269 | 23269 | Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects | Completed | No Results Available | Healthy | Drug: PEG 400|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02260076 |
| 23270 | 23270 | Relative Bioavailability of Epinastine Syrup Compared to Tablets in Healthy Volunteers | Completed | No Results Available | Healthy | Drug: Epinastine syrup|Drug: Epinastine tablets | https://ClinicalTrials.gov/show/NCT02260063 |
| 23271 | 23271 | Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: WAL 801 CL dry syrup new formulation|Drug: WAL 801 CL dry syrup conventional formulation | https://ClinicalTrials.gov/show/NCT02260050 |
| 23272 | 23272 | Dose Tolerance Study in Healthy Male Volunteers After Intranasal Application of Epinastine Nasal | Completed | No Results Available | Healthy | Drug: Epinastine nasal|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02260037 |
| 23273 | 23273 | In Vitro/in Vivo Correlation (IVIVC) for Oral Slow Release (SR) Tablets Pramipexole in Healthy Male Volunteers | Completed | No Results Available | Healthy | Other: High fat, high caloric meal|Drug: Pramipexole IR tablets|Drug: Pramipexole SR C|Drug: Pramipexole SR C2|Drug: Pramipexole SR C2A|Drug: Pramipexole SR C2B | https://ClinicalTrials.gov/show/NCT02260024 |
| 23274 | 23274 | Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease | Completed | No Results Available | Pulmonary Disease, Chronic Obstructive | Drug: Ipratropium bromide HFA-134a inhalation aerosol|Drug: Atrovent® CFC inhalation aerosol|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02260011 |
| 23275 | 23275 | Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: Persantin® new formulation|Drug: Persantin® commercial formulation | https://ClinicalTrials.gov/show/NCT02259998 |
| 23276 | 23276 | Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects | Completed | No Results Available | Healthy | Drug: Itasetron tablet|Drug: Itasetron infusion|Other: high fat breakfast | https://ClinicalTrials.gov/show/NCT02259985 |
| 23277 | 23277 | Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: BI 113823 solution|Drug: BI 113823 tablet|Drug: Placebo|Other: High fat, high calorie breakfast | https://ClinicalTrials.gov/show/NCT02259972 |
| 23278 | 23278 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: Single rising doses of BI 1744 CL, solution for oral inhalation|Drug: Tiotropium, fixed dose, solution for oral inhalation|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02259959 |
| 23279 | 23279 | Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: BI 1744 CL|Drug: Placebo|Drug: Tiotropium bromide | https://ClinicalTrials.gov/show/NCT02259946 |
| 23280 | 23280 | Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: KUC 7483 CL|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02259933 |